People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Novellus LLC | — | Pharmaceuticals | Pre-Seed | $3.0M | $47.3M | 2016 |
| Factor Bioscience LLC | — | Biotechnology | Pre-Seed | $1.0M | $2.2M | 2025 |
| Novellus, Inc. | — | Pharmaceuticals | Pre-Seed | $250K | $11.8M | 2014 |
Christopher Rohde at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher Rohde on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Angel | 3 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.